Global Continuous Renal Replacement Therapy Market
Global Continuous Renal Replacement Therapy Market

Continuous Renal Replacement Therapy Comprehensive Study by Type (Dialysis System, Consumables), Application (Hospitals, Dialysis Clinics), Therapy (Renal care, Non-renal care), Mode (Continuous Veno Venous Hemodialysis (CVVDH), Continuous Veno Venous Hemofiltration (CVVH), Continuous Veno Venous Hemodiafiltration (CVVHDF), Slow Continuous Ultrafiltration (SCUF), Therapeutic Plasma Exchange (TPE)) Players and Region - Global Market Outlook to 2026

Continuous Renal Replacement Therapy Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Mar 2021 Edition 237 Pages 222 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Continuous Renal Replacement Therapy Market Overview:
Continuous Renal Replacement Therapy (CRRT) is primarily performed For Hemodynamically Unstable Patients who suffer from Acute Kidney Injury. Acute Kidney Injury is associated with Severe Morbidity which can be Fatal. CRRT is similar to Haemodialysis Technique. However, CRRT uses advance principles including Convection, Ultra-Filtration and Diffusion. Patients who undergo Continuous Renal Replacement Therapies are vulnerable to many complications such as Hypotension, Bleeding and Coagulopathy and Infection especially when they are critically ill. Continuous Renal Replacement Therapy is performed through Different Modalities Namely, Intermittent Hemodialysis (IHD), and the Prolonged Intermittent Renal Replacement Therapies (PIRRTs), which is a Hybrid mode of CRRT and IHD.

Growth Drivers
  • Prevalence of Renal Diseases.
  • Medical Industry Highly in demand.

Market Trends
  • Technical Progress in Medical Industry.
  • Medical Degrees have become Significantly Popular.

Roadblocks
  • Lack of Trained Professionals.

Opportunities
  • Highly complex Medical Procedures can be Performed with Ease.
  • Growing reach across Emerging Economies.

Challenges
  • Fierce competitive pressure.
  • Complicated Procedures.


Competitive Landscape:
Continuous Renal Replacement Therapy Market comprises of High Degree of competition, well established players have an Edge over the new Entrants in terms of customer base & Better serviceability & Regulatory approval for the products & understand the consumer requirements well. Players are concentrated Majority in North America, Europe & Asia particularly in the United States, Italy & Japan. Currently key players are in the industry are looking to enhance their existing range of product by Implementing advance Technologies and at the same time deliver quality Dialysis Systems for changing regulatory Environment across core areas including Healthcare. No significant Merger & Acquisitions have happened in the recent years thus indicating towards the growth potential in the Continuous Renal Replacement Therapy Market.
Some of the key players profiled in the report are Baxter International Inc. (United States), Fresenius Medical Care AG & Co. KGAA (Germany), Nikkiso Co., Ltd. (Japan), B. Braun (Germany), Nxstage Medical, Inc. (United States), Asahi Kasei Medical Co., Ltd. (Japan), Bellco S.R.L. (Italy), Infomed SA (Switzerland), SWS Hemodialysis Care Co. (China), MEDICA S.p.A (Italy) and Medtronic PLC (United States). Analyst at AMA Research see United States, Japanese and Italian Players to retain maximum share of Global Continuous Renal Replacement Therapy market by 2026. Considering Market by Therapy, the sub-segment i.e. Renal care will boost the Continuous Renal Replacement Therapy market. Considering Market by Mode, the sub-segment i.e. Continuous Veno Venous Hemodialysis (CVVDH) will boost the Continuous Renal Replacement Therapy market.

On 12th March, 2021 - FDA Approved clearance to Baxter's latest Portable In-centre Dialysis Machine. Baxter plans to make additional investments in 2021 to its Manufacturing Capacity particularly for its Renal Segment. and On 11th March, 2021 -CHF Solutions Submitted Application to Patent its Newly Launched “Aquadex SmartFlow” which uses Peripheral Venous Access Technology built for Ultrafiltration and CRRT Systems

United States Food & Drug Administration; Issued Guidelines & Regulations for Continuous Renal Replacement Therapy Procedure, the guide contains a list of approved Devices and Marketing agencies. New Entrants are required to get their Product Approved from USFDA. and Ministry of Health & Family Welfare Govt. of India “Standard Treatment Guidelines Haemodialysis” – Chapter 22 of the comprehensive Guidelines includes Standards and Recommendations for Renal Replacement Therapy Procedure.

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Continuous Renal Replacement Therapy market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Continuous Renal Replacement Therapy market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants & Investors, Research, Education & Training institutions, CRRT Manufacturers, Suppliers, Distributers & Dealers of Dialysis Systems, End Use Industries, Hospitals & Clinics, Analysts and Strategic Business Planners, Venture Capitalists and Private Equity Firms and Government Bodies.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Dialysis System
  • Consumables
By Application
  • Hospitals
  • Dialysis Clinics
By Therapy
  • Renal care
  • Non-renal care

By Mode
  • Continuous Veno Venous Hemodialysis (CVVDH)
  • Continuous Veno Venous Hemofiltration (CVVH)
  • Continuous Veno Venous Hemodiafiltration (CVVHDF)
  • Slow Continuous Ultrafiltration (SCUF)
  • Therapeutic Plasma Exchange (TPE)

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Prevalence of Renal Diseases.
      • 3.2.2. Medical Industry Highly in demand.
    • 3.3. Market Challenges
      • 3.3.1. Fierce competitive pressure.
      • 3.3.2. Complicated Procedures.
    • 3.4. Market Trends
      • 3.4.1. Technical Progress in Medical Industry.
      • 3.4.2. Medical Degrees have become Significantly Popular.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Continuous Renal Replacement Therapy, by Type, Application, Therapy, Mode and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Continuous Renal Replacement Therapy (Value)
      • 5.2.1. Global Continuous Renal Replacement Therapy by: Type (Value)
        • 5.2.1.1. Dialysis System
        • 5.2.1.2. Consumables
      • 5.2.2. Global Continuous Renal Replacement Therapy by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Dialysis Clinics
      • 5.2.3. Global Continuous Renal Replacement Therapy by: Therapy (Value)
        • 5.2.3.1. Renal care
        • 5.2.3.2. Non-renal care
      • 5.2.4. Global Continuous Renal Replacement Therapy by: Mode (Value)
        • 5.2.4.1. Continuous Veno Venous Hemodialysis (CVVDH)
        • 5.2.4.2. Continuous Veno Venous Hemofiltration (CVVH)
        • 5.2.4.3. Continuous Veno Venous Hemodiafiltration (CVVHDF)
        • 5.2.4.4. Slow Continuous Ultrafiltration (SCUF)
        • 5.2.4.5. Therapeutic Plasma Exchange (TPE)
      • 5.2.5. Global Continuous Renal Replacement Therapy Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Continuous Renal Replacement Therapy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Baxter International Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Fresenius Medical Care AG & Co. KGAA (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Nikkiso Co., Ltd. (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. B. Braun (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Nxstage Medical, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Asahi Kasei Medical Co., Ltd. (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bellco S.R.L. (Italy)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Infomed SA (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. SWS Hemodialysis Care Co. (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. MEDICA S.p.A (Italy)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Medtronic PLC (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Continuous Renal Replacement Therapy Sale, by Type, Application, Therapy, Mode and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Continuous Renal Replacement Therapy (Value)
      • 7.2.1. Global Continuous Renal Replacement Therapy by: Type (Value)
        • 7.2.1.1. Dialysis System
        • 7.2.1.2. Consumables
      • 7.2.2. Global Continuous Renal Replacement Therapy by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Dialysis Clinics
      • 7.2.3. Global Continuous Renal Replacement Therapy by: Therapy (Value)
        • 7.2.3.1. Renal care
        • 7.2.3.2. Non-renal care
      • 7.2.4. Global Continuous Renal Replacement Therapy by: Mode (Value)
        • 7.2.4.1. Continuous Veno Venous Hemodialysis (CVVDH)
        • 7.2.4.2. Continuous Veno Venous Hemofiltration (CVVH)
        • 7.2.4.3. Continuous Veno Venous Hemodiafiltration (CVVHDF)
        • 7.2.4.4. Slow Continuous Ultrafiltration (SCUF)
        • 7.2.4.5. Therapeutic Plasma Exchange (TPE)
      • 7.2.5. Global Continuous Renal Replacement Therapy Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Continuous Renal Replacement Therapy: by Type(USD Million)
  • Table 2. Continuous Renal Replacement Therapy Dialysis System , by Region USD Million (2015-2020)
  • Table 3. Continuous Renal Replacement Therapy Consumables , by Region USD Million (2015-2020)
  • Table 4. Continuous Renal Replacement Therapy: by Application(USD Million)
  • Table 5. Continuous Renal Replacement Therapy Hospitals , by Region USD Million (2015-2020)
  • Table 6. Continuous Renal Replacement Therapy Dialysis Clinics , by Region USD Million (2015-2020)
  • Table 7. Continuous Renal Replacement Therapy: by Therapy(USD Million)
  • Table 8. Continuous Renal Replacement Therapy Renal care , by Region USD Million (2015-2020)
  • Table 9. Continuous Renal Replacement Therapy Non-renal care , by Region USD Million (2015-2020)
  • Table 10. Continuous Renal Replacement Therapy: by Mode(USD Million)
  • Table 11. Continuous Renal Replacement Therapy Continuous Veno Venous Hemodialysis (CVVDH) , by Region USD Million (2015-2020)
  • Table 12. Continuous Renal Replacement Therapy Continuous Veno Venous Hemofiltration (CVVH) , by Region USD Million (2015-2020)
  • Table 13. Continuous Renal Replacement Therapy Continuous Veno Venous Hemodiafiltration (CVVHDF) , by Region USD Million (2015-2020)
  • Table 14. Continuous Renal Replacement Therapy Slow Continuous Ultrafiltration (SCUF) , by Region USD Million (2015-2020)
  • Table 15. Continuous Renal Replacement Therapy Therapeutic Plasma Exchange (TPE) , by Region USD Million (2015-2020)
  • Table 16. South America Continuous Renal Replacement Therapy, by Country USD Million (2015-2020)
  • Table 17. South America Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 18. South America Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 19. South America Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 20. South America Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 21. Brazil Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 22. Brazil Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 23. Brazil Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 24. Brazil Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 25. Argentina Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 26. Argentina Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 27. Argentina Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 28. Argentina Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 29. Rest of South America Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 30. Rest of South America Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 31. Rest of South America Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 32. Rest of South America Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 33. Asia Pacific Continuous Renal Replacement Therapy, by Country USD Million (2015-2020)
  • Table 34. Asia Pacific Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 35. Asia Pacific Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 36. Asia Pacific Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 37. Asia Pacific Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 38. China Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 39. China Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 40. China Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 41. China Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 42. Japan Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 43. Japan Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 44. Japan Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 45. Japan Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 46. India Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 47. India Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 48. India Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 49. India Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 50. South Korea Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 51. South Korea Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 52. South Korea Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 53. South Korea Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 54. Taiwan Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 55. Taiwan Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 56. Taiwan Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 57. Taiwan Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 58. Australia Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 59. Australia Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 60. Australia Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 61. Australia Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 66. Europe Continuous Renal Replacement Therapy, by Country USD Million (2015-2020)
  • Table 67. Europe Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 68. Europe Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 69. Europe Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 70. Europe Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 71. Germany Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 72. Germany Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 73. Germany Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 74. Germany Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 75. France Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 76. France Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 77. France Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 78. France Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 79. Italy Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 80. Italy Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 81. Italy Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 82. Italy Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 83. United Kingdom Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 84. United Kingdom Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 85. United Kingdom Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 86. United Kingdom Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 87. Netherlands Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 88. Netherlands Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 89. Netherlands Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 90. Netherlands Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 91. Rest of Europe Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 92. Rest of Europe Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 93. Rest of Europe Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 94. Rest of Europe Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 95. MEA Continuous Renal Replacement Therapy, by Country USD Million (2015-2020)
  • Table 96. MEA Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 97. MEA Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 98. MEA Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 99. MEA Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 100. Middle East Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 101. Middle East Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 102. Middle East Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 103. Middle East Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 104. Africa Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 105. Africa Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 106. Africa Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 107. Africa Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 108. North America Continuous Renal Replacement Therapy, by Country USD Million (2015-2020)
  • Table 109. North America Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 110. North America Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 111. North America Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 112. North America Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 113. United States Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 114. United States Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 115. United States Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 116. United States Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 117. Canada Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 118. Canada Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 119. Canada Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 120. Canada Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 121. Mexico Continuous Renal Replacement Therapy, by Type USD Million (2015-2020)
  • Table 122. Mexico Continuous Renal Replacement Therapy, by Application USD Million (2015-2020)
  • Table 123. Mexico Continuous Renal Replacement Therapy, by Therapy USD Million (2015-2020)
  • Table 124. Mexico Continuous Renal Replacement Therapy, by Mode USD Million (2015-2020)
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Continuous Renal Replacement Therapy: by Type(USD Million)
  • Table 137. Continuous Renal Replacement Therapy Dialysis System , by Region USD Million (2021-2026)
  • Table 138. Continuous Renal Replacement Therapy Consumables , by Region USD Million (2021-2026)
  • Table 139. Continuous Renal Replacement Therapy: by Application(USD Million)
  • Table 140. Continuous Renal Replacement Therapy Hospitals , by Region USD Million (2021-2026)
  • Table 141. Continuous Renal Replacement Therapy Dialysis Clinics , by Region USD Million (2021-2026)
  • Table 142. Continuous Renal Replacement Therapy: by Therapy(USD Million)
  • Table 143. Continuous Renal Replacement Therapy Renal care , by Region USD Million (2021-2026)
  • Table 144. Continuous Renal Replacement Therapy Non-renal care , by Region USD Million (2021-2026)
  • Table 145. Continuous Renal Replacement Therapy: by Mode(USD Million)
  • Table 146. Continuous Renal Replacement Therapy Continuous Veno Venous Hemodialysis (CVVDH) , by Region USD Million (2021-2026)
  • Table 147. Continuous Renal Replacement Therapy Continuous Veno Venous Hemofiltration (CVVH) , by Region USD Million (2021-2026)
  • Table 148. Continuous Renal Replacement Therapy Continuous Veno Venous Hemodiafiltration (CVVHDF) , by Region USD Million (2021-2026)
  • Table 149. Continuous Renal Replacement Therapy Slow Continuous Ultrafiltration (SCUF) , by Region USD Million (2021-2026)
  • Table 150. Continuous Renal Replacement Therapy Therapeutic Plasma Exchange (TPE) , by Region USD Million (2021-2026)
  • Table 151. South America Continuous Renal Replacement Therapy, by Country USD Million (2021-2026)
  • Table 152. South America Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 153. South America Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 154. South America Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 155. South America Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 156. Brazil Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 157. Brazil Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 158. Brazil Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 159. Brazil Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 160. Argentina Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 161. Argentina Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 162. Argentina Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 163. Argentina Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 164. Rest of South America Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 165. Rest of South America Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 166. Rest of South America Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 167. Rest of South America Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 168. Asia Pacific Continuous Renal Replacement Therapy, by Country USD Million (2021-2026)
  • Table 169. Asia Pacific Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 170. Asia Pacific Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 171. Asia Pacific Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 172. Asia Pacific Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 173. China Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 174. China Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 175. China Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 176. China Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 177. Japan Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 178. Japan Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 179. Japan Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 180. Japan Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 181. India Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 182. India Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 183. India Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 184. India Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 185. South Korea Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 186. South Korea Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 187. South Korea Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 188. South Korea Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 189. Taiwan Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 190. Taiwan Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 191. Taiwan Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 192. Taiwan Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 193. Australia Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 194. Australia Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 195. Australia Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 196. Australia Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 197. Rest of Asia-Pacific Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 198. Rest of Asia-Pacific Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 199. Rest of Asia-Pacific Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 200. Rest of Asia-Pacific Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 201. Europe Continuous Renal Replacement Therapy, by Country USD Million (2021-2026)
  • Table 202. Europe Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 203. Europe Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 204. Europe Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 205. Europe Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 206. Germany Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 207. Germany Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 208. Germany Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 209. Germany Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 210. France Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 211. France Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 212. France Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 213. France Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 214. Italy Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 215. Italy Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 216. Italy Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 217. Italy Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 218. United Kingdom Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 219. United Kingdom Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 220. United Kingdom Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 221. United Kingdom Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 222. Netherlands Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 223. Netherlands Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 224. Netherlands Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 225. Netherlands Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 226. Rest of Europe Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 227. Rest of Europe Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 228. Rest of Europe Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 229. Rest of Europe Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 230. MEA Continuous Renal Replacement Therapy, by Country USD Million (2021-2026)
  • Table 231. MEA Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 232. MEA Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 233. MEA Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 234. MEA Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 235. Middle East Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 236. Middle East Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 237. Middle East Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 238. Middle East Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 239. Africa Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 240. Africa Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 241. Africa Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 242. Africa Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 243. North America Continuous Renal Replacement Therapy, by Country USD Million (2021-2026)
  • Table 244. North America Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 245. North America Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 246. North America Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 247. North America Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 248. United States Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 249. United States Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 250. United States Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 251. United States Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 252. Canada Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 253. Canada Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 254. Canada Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 255. Canada Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 256. Mexico Continuous Renal Replacement Therapy, by Type USD Million (2021-2026)
  • Table 257. Mexico Continuous Renal Replacement Therapy, by Application USD Million (2021-2026)
  • Table 258. Mexico Continuous Renal Replacement Therapy, by Therapy USD Million (2021-2026)
  • Table 259. Mexico Continuous Renal Replacement Therapy, by Mode USD Million (2021-2026)
  • Table 260. Research Programs/Design for This Report
  • Table 261. Key Data Information from Secondary Sources
  • Table 262. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Continuous Renal Replacement Therapy: by Type USD Million (2015-2020)
  • Figure 5. Global Continuous Renal Replacement Therapy: by Application USD Million (2015-2020)
  • Figure 6. Global Continuous Renal Replacement Therapy: by Therapy USD Million (2015-2020)
  • Figure 7. Global Continuous Renal Replacement Therapy: by Mode USD Million (2015-2020)
  • Figure 8. South America Continuous Renal Replacement Therapy Share (%), by Country
  • Figure 9. Asia Pacific Continuous Renal Replacement Therapy Share (%), by Country
  • Figure 10. Europe Continuous Renal Replacement Therapy Share (%), by Country
  • Figure 11. MEA Continuous Renal Replacement Therapy Share (%), by Country
  • Figure 12. North America Continuous Renal Replacement Therapy Share (%), by Country
  • Figure 13. Global Continuous Renal Replacement Therapy share by Players 2020 (%)
  • Figure 14. Global Continuous Renal Replacement Therapy share by Players (Top 3) 2020(%)
  • Figure 15. Global Continuous Renal Replacement Therapy share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Baxter International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Baxter International Inc. (United States) Revenue: by Geography 2020
  • Figure 19. Fresenius Medical Care AG & Co. KGAA (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Fresenius Medical Care AG & Co. KGAA (Germany) Revenue: by Geography 2020
  • Figure 21. Nikkiso Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 22. Nikkiso Co., Ltd. (Japan) Revenue: by Geography 2020
  • Figure 23. B. Braun (Germany) Revenue, Net Income and Gross profit
  • Figure 24. B. Braun (Germany) Revenue: by Geography 2020
  • Figure 25. Nxstage Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Nxstage Medical, Inc. (United States) Revenue: by Geography 2020
  • Figure 27. Asahi Kasei Medical Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 28. Asahi Kasei Medical Co., Ltd. (Japan) Revenue: by Geography 2020
  • Figure 29. Bellco S.R.L. (Italy) Revenue, Net Income and Gross profit
  • Figure 30. Bellco S.R.L. (Italy) Revenue: by Geography 2020
  • Figure 31. Infomed SA (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. Infomed SA (Switzerland) Revenue: by Geography 2020
  • Figure 33. SWS Hemodialysis Care Co. (China) Revenue, Net Income and Gross profit
  • Figure 34. SWS Hemodialysis Care Co. (China) Revenue: by Geography 2020
  • Figure 35. MEDICA S.p.A (Italy) Revenue, Net Income and Gross profit
  • Figure 36. MEDICA S.p.A (Italy) Revenue: by Geography 2020
  • Figure 37. Medtronic PLC (United States) Revenue, Net Income and Gross profit
  • Figure 38. Medtronic PLC (United States) Revenue: by Geography 2020
  • Figure 39. Global Continuous Renal Replacement Therapy: by Type USD Million (2021-2026)
  • Figure 40. Global Continuous Renal Replacement Therapy: by Application USD Million (2021-2026)
  • Figure 41. Global Continuous Renal Replacement Therapy: by Therapy USD Million (2021-2026)
  • Figure 42. Global Continuous Renal Replacement Therapy: by Mode USD Million (2021-2026)
  • Figure 43. South America Continuous Renal Replacement Therapy Share (%), by Country
  • Figure 44. Asia Pacific Continuous Renal Replacement Therapy Share (%), by Country
  • Figure 45. Europe Continuous Renal Replacement Therapy Share (%), by Country
  • Figure 46. MEA Continuous Renal Replacement Therapy Share (%), by Country
  • Figure 47. North America Continuous Renal Replacement Therapy Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Baxter International Inc. (United States)
  • Fresenius Medical Care AG & Co. KGAA (Germany)
  • Nikkiso Co., Ltd. (Japan)
  • B. Braun (Germany)
  • Nxstage Medical, Inc. (United States)
  • Asahi Kasei Medical Co., Ltd. (Japan)
  • Bellco S.R.L. (Italy)
  • Infomed SA (Switzerland)
  • SWS Hemodialysis Care Co. (China)
  • MEDICA S.p.A (Italy)
  • Medtronic PLC (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation